|Articles|September 1, 2003
5-Fluorouracil Combo Promising
Author(s)Lawrence M. Prescott, Ph.D.
Chicago - The combination of oxaliplatin (Eloxatin) and a continuous infusion of 5-fluorouracil (5-FU) appears to offer a promising chemotherapeutic alternative to the presently administered cisplatin or carboplatin-based approach for the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck, Marc Debled, M.D., said at the American Society of Clinical Oncology meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Peter Lio, MD, Discusses Atopic Dermatitis Treatment Strategy and Microbiome-Targeted Therapies
2
The Dermatologist's Dilemma: Two Cases That Remind Us to Be Detectives
3
Clear Health Launches Topical Isotretinoin Acne Treatment Without iPLEDGE Requirements
4
Topical DB-006 Shows Strong Efficacy, Safety in Preclinical AD Model
5









